These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21173171)

  • 1. Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studies.
    Douglas JB; Silverman DT; Weinstein SJ; Graubard BI; Pollak MN; Tao Y; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):359-69. PubMed ID: 21173171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial DNA copy number and pancreatic cancer in the alpha-tocopherol beta-carotene cancer prevention study.
    Lynch SM; Weinstein SJ; Virtamo J; Lan Q; Liu CS; Cheng WL; Rothman N; Albanes D; Stolzenberg-Solomon RZ
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1912-9. PubMed ID: 21859925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies.
    Jacobs EJ; Newton CC; Silverman DT; Nogueira LM; Albanes D; Männistö S; Pollak M; Stolzenberg-Solomon RZ
    Cancer Causes Control; 2014 Sep; 25(9):1083-91. PubMed ID: 24913781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts.
    Stolzenberg-Solomon RZ; Newton CC; Silverman DT; Pollak M; Nogueira LM; Weinstein SJ; Albanes D; Männistö S; Jacobs EJ
    Am J Epidemiol; 2015 Aug; 182(3):187-97. PubMed ID: 26085045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum selenium and pancreatic cancer: a prospective study in the Prostate, Lung, Colorectal and Ovarian Cancer Trial cohort.
    Chatterjee S; Combs GF; Chattopadhyay A; Stolzenberg-Solomon R
    Cancer Causes Control; 2019 May; 30(5):457-464. PubMed ID: 30915619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin E intake, alpha-tocopherol status, and pancreatic cancer in a cohort of male smokers.
    Stolzenberg-Solomon RZ; Sheffler-Collins S; Weinstein S; Garabrant DH; Mannisto S; Taylor P; Virtamo J; Albanes D
    Am J Clin Nutr; 2009 Feb; 89(2):584-91. PubMed ID: 19116326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective analysis of telomere length and pancreatic cancer in the alpha-tocopherol beta-carotene cancer (ATBC) prevention study.
    Lynch SM; Major JM; Cawthon R; Weinstein SJ; Virtamo J; Lan Q; Rothman N; Albanes D; Stolzenberg-Solomon RZ
    Int J Cancer; 2013 Dec; 133(11):2672-80. PubMed ID: 23674344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocolpherol, beta-carotene cancer prevention (ATBC) study.
    Mondul AM; Moore SC; Weinstein SJ; Karoly ED; Sampson JN; Albanes D
    Int J Cancer; 2015 Nov; 137(9):2124-32. PubMed ID: 25904191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants.
    Andreotti G; Karami S; Pfeiffer RM; Hurwitz L; Liao LM; Weinstein SJ; Albanes D; Virtamo J; Silverman DT; Rothman N; Moore LE
    Epigenetics; 2014 Mar; 9(3):404-15. PubMed ID: 24316677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum C-peptide, Total and High Molecular Weight Adiponectin, and Pancreatic Cancer: Do Associations Differ by Smoking?
    Nogueira LM; Newton CC; Pollak M; Silverman DT; Albanes D; Männistö S; Weinstein SJ; Jacobs EJ; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):914-922. PubMed ID: 28096201
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial.
    Stolzenberg-Solomon RZ; Hayes RB; Horst RL; Anderson KE; Hollis BW; Silverman DT
    Cancer Res; 2009 Feb; 69(4):1439-47. PubMed ID: 19208842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers.
    Stolzenberg-Solomon RZ; Weinstein S; Pollak M; Tao Y; Taylor PR; Virtamo J; Albanes D
    Am J Epidemiol; 2008 Nov; 168(9):1047-55. PubMed ID: 18801887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipidomics and pancreatic cancer risk in two prospective studies.
    Naudin S; Sampson JN; Moore SC; Albanes D; Freedman ND; Weinstein SJ; Stolzenberg-Solomon R
    Eur J Epidemiol; 2023 Jul; 38(7):783-793. PubMed ID: 37169992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.
    Pine SR; Mechanic LE; Enewold L; Chaturvedi AK; Katki HA; Zheng YL; Bowman ED; Engels EA; Caporaso NE; Harris CC
    J Natl Cancer Inst; 2011 Jul; 103(14):1112-22. PubMed ID: 21685357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D-binding protein and pancreatic cancer: a nested case-control study.
    Piper MR; Freedman DM; Robien K; Kopp W; Rager H; Horst RL; Stolzenberg-Solomon RZ
    Am J Clin Nutr; 2015 Jun; 101(6):1206-15. PubMed ID: 25904602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma carotenoids, vitamin C, retinol and tocopherols levels and pancreatic cancer risk within the European Prospective Investigation into Cancer and Nutrition: a nested case-control study: plasma micronutrients and pancreatic cancer risk.
    Jeurnink SM; Ros MM; Leenders M; van Duijnhoven FJ; Siersema PD; Jansen EH; van Gils CH; Bakker MF; Overvad K; Roswall N; Tjønneland A; Boutron-Ruault MC; Racine A; Cadeau C; Grote V; Kaaks R; Aleksandrova K; Boeing H; Trichopoulou A; Benetou V; Valanou E; Palli D; Krogh V; Vineis P; Tumino R; Mattiello A; Weiderpass E; Skeie G; Castaño JM; Duell EJ; Barricarte A; Molina-Montes E; Argüelles M; Dorronsoro M; Johansen D; Lindkvist B; Sund M; Crowe FL; Khaw KT; Jenab M; Fedirko V; Riboli E; Bueno-de-Mesquita HB
    Int J Cancer; 2015 Mar; 136(6):E665-76. PubMed ID: 25175624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
    Stolzenberg-Solomon RZ; Jacobs EJ; Arslan AA; Qi D; Patel AV; Helzlsouer KJ; Weinstein SJ; McCullough ML; Purdue MP; Shu XO; Snyder K; Virtamo J; Wilkins LR; Yu K; Zeleniuch-Jacquotte A; Zheng W; Albanes D; Cai Q; Harvey C; Hayes R; Clipp S; Horst RL; Irish L; Koenig K; Le Marchand L; Kolonel LN
    Am J Epidemiol; 2010 Jul; 172(1):81-93. PubMed ID: 20562185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disentangling discordant vitamin D associations with prostate cancer incidence and fatality in a large, nested case-control study.
    Etiévant L; Gail MH; Albanes D
    Int J Epidemiol; 2024 Aug; 53(5):. PubMed ID: 39180769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum immunoglobulin e and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Olson SH; Hsu M; Wiemels JL; Bracci PM; Zhou M; Patoka J; Reisacher WR; Wang J; Kurtz RC; Silverman DT; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1414-20. PubMed ID: 24718282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.